TGFB1 and COVID-19: Considering that TGF-β suppresses the inflammatory activity of diverse immune cells and contributes to tissue regeneration and wound healing, the current data suggest that corticosteroid treatment plays dual roles, namely, anti-inflammatory and tissue-regenerative functions, in patients with severe COVID-19.